This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the supply of LINZESS 290 MCG CAPSULE in quantities of 30s, with a firm fixed price of $11,513.57 and a completion date of September 19, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, and this order is part of...
This is a delivery order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,715.99 firm-fixed-price contract is for the delivery of LINZESS 72 MCG CAPSULE UU 30S pharmaceutical products. The contract has a completion date of May 23, 2025 and is not set aside for any socioeconomic program. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $1,704.54 firm fixed price contract is for the delivery of LINZESS 145 MCG capsules. The contract has an ultimate completion date of October 16, 2024. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies to various government agencies. This order is likely part of a larger indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $7,554.64 firm-fixed-price contract is for the supply of LINZESS 290 MCG capsules, a prescription medication. It has an ultimate completion date of April 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with the DLA Troop Support Medical,...
This is a $1,728.83 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for LINZESS 145 MCG CAPSULE UU 30S, a pharmaceutical product. The contract has an ultimate completion date of July 16, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and...
This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,398.87, is for the supply of LINZESS 290MG CAP 30S, a medication. The contract has an ultimate completion date of November 19, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,628.69 firm fixed-price contract is for the delivery of LINZESS 72 MCG CAPSULE UU 30S, a specialty pharmaceutical product. The contract has an ultimate completion date of December 19, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The order is for the delivery of LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product, with a potential value of $3,999.73 and a completion date of January 5, 2024. This order was placed under a larger indefinite delivery contract held by Amerisourcebergen...
This federal contract award, valued at $1,891.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LINZESS 72 MCG CAPSULE UU 30S, a pharmaceutical product, with a performance period extending through May 12, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a $4,564.79 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LINZESS 145 MCG CAPSULE UU 30S, a medication product. The contract has an ultimate completion date of June 25, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...